ONTOLOGY REPORT - ANNOTATIONS
|
||||||||||||||||||||||||||||||||||
L-ascorbic acid
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | AARS | alanyl-tRNA synthetase |
|
decreases expression | EXP | 16 | 70,286,297 | 70,323,412 | RGD:6480464 | CTD | |
| G | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
|
multiple interactions | EXP | 9 | 107,543,283 | 107,690,527 | RGD:6480464 | CTD | |
| G | ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
|
multiple interactions | EXP | 7 | 87,133,179 | 87,342,639 | RGD:6480464 | CTD | |
| G | ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions | EXP | 16 | 16,043,434 | 16,236,931 | RGD:6480464 | CTD | |
| G | ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
multiple interactions | EXP | 10 | 101,542,463 | 101,611,662 | RGD:6480464 | CTD | |
| G | ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
multiple interactions | EXP | 10 | 101,542,463 | 101,611,662 | RGD:6480464 | CTD | |
| G | ACE2 | angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
|
multiple interactions | EXP | X | 15,579,156 | 15,620,192 | RGD:6480464 | CTD | |
| G | ACHE | acetylcholinesterase |
|
decreases activity | ISO | 7 | 100,487,615 | 100,493,541 | RGD:6480464 | CTD | |
| G | ACHE | acetylcholinesterase |
|
multiple interactions | ISO | 7 | 100,487,615 | 100,493,541 | RGD:6480464 | CTD | |
| G | ACHE | acetylcholinesterase |
|
increases activity | ISO | 7 | 100,487,615 | 100,493,541 | RGD:6480464 | CTD | |
| G | ACHE | acetylcholinesterase |
|
multiple interactions | ISO | 7 | 100,487,615 | 100,493,541 | RGD:6480464 | CTD | |
| G | ACHE | acetylcholinesterase |
|
multiple interactions | ISO | 7 | 100,487,615 | 100,493,541 | RGD:6480464 | CTD | |
| G | ACSL4 | acyl-CoA synthetase long-chain family member 4 |
|
decreases expression | ISO | X | 108,884,564 | 108,976,621 | RGD:6480464 | CTD | |
| G | ACTA2 | actin, alpha 2, smooth muscle, aorta |
|
multiple interactions | EXP | 10 | 90,694,831 | 90,751,147 | RGD:6480464 | CTD | |
| G | ACTA2 | actin, alpha 2, smooth muscle, aorta |
|
multiple interactions | ISO | 10 | 90,694,831 | 90,751,147 | RGD:6480464 | CTD | |
| G | ACTA2 | actin, alpha 2, smooth muscle, aorta |
|
multiple interactions | EXP | 10 | 90,694,831 | 90,751,147 | RGD:6480464 | CTD | |
| G | ACTA2 | actin, alpha 2, smooth muscle, aorta |
|
multiple interactions | ISO | 10 | 90,694,831 | 90,751,147 | RGD:6480464 | CTD | |
| G | ADCY6 | adenylate cyclase 6 |
|
decreases expression | EXP | 12 | 49,159,975 | 49,182,820 | RGD:6480464 | CTD | |
| G | AGO2 | argonaute RISC catalytic component 2 |
|
decreases expression | ISO | 8 | 141,541,264 | 141,645,646 | RGD:6480464 | CTD | |
| G | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions | ISO | 1 | 230,838,269 | 230,850,336 | RGD:6480464 | CTD | |
| G | AK4 | adenylate kinase 4 |
|
decreases expression | ISO | 1 | 65,613,232 | 65,697,828 | RGD:6480464 | CTD | |
| G | AKR1B1 | aldo-keto reductase family 1, member B1 (aldose reductase) |
|
increases reduction | EXP | 7 | 134,127,107 | 134,143,888 | RGD:6480464 | CTD | |
| G | AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions | ISO | 14 | 105,235,686 | 105,262,080 | RGD:6480464 | CTD | |
| G | AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions | ISO | 14 | 105,235,686 | 105,262,080 | RGD:6480464 | CTD | |
| G | ALPI | alkaline phosphatase, intestinal |
|
multiple interactions | EXP | 2 | 233,320,833 | 233,324,742 | RGD:6480464 | CTD | |
| G | ANPEP | alanyl (membrane) aminopeptidase |
|
multiple interactions | EXP | 15 | 90,328,126 | 90,358,072 | RGD:6480464 | CTD | |
| G | ANXA1 | annexin A1 |
|
multiple interactions | EXP | 9 | 75,766,781 | 75,785,307 | RGD:6480464 | CTD | |
| G | ANXA1 | annexin A1 |
|
increases expression | ISO | 9 | 75,766,781 | 75,785,307 | RGD:6480464 | CTD | |
| G | ANXA5 | annexin A5 |
|
multiple interactions | ISO | 4 | 122,589,152 | 122,618,147 | RGD:6480464 | CTD | |
| G | ANXA5 | annexin A5 |
|
increases expression | ISO | 4 | 122,589,152 | 122,618,147 | RGD:6480464 | CTD | |
| G | ANXA5 | annexin A5 |
|
increases expression | ISO | 4 | 122,589,152 | 122,618,147 | RGD:6480464 | CTD | |
| G | APOA1 | apolipoprotein A-I |
|
decreases expression | EXP | 11 | 116,706,469 | 116,708,338 | RGD:6480464 | CTD | |
| G | APOA1 | apolipoprotein A-I |
|
decreases activity | ISO | 11 | 116,706,469 | 116,708,338 | RGD:6480464 | CTD | |
| G | APOB | apolipoprotein B |
|
multiple interactions | EXP | 2 | 21,224,301 | 21,266,945 | RGD:6480464 | CTD | |
| G | APOB | apolipoprotein B |
|
multiple interactions | EXP | 2 | 21,224,301 | 21,266,945 | RGD:6480464 | CTD | |
| G | APOE | apolipoprotein E |
|
increases expression | ISO | 19 | 45,409,039 | 45,412,650 | RGD:6480464 | CTD | |
| G | APOM | apolipoprotein M |
|
multiple interactions | EXP | 6 | 31,620,187 | 31,625,987 | RGD:6480464 | CTD | |
| G | APP | amyloid beta (A4) precursor protein |
|
increases oxidation | EXP | 21 | 27,252,861 | 27,543,446 | RGD:6480464 | CTD | |
| G | APP | amyloid beta (A4) precursor protein |
|
multiple interactions | EXP | 21 | 27,252,861 | 27,543,446 | RGD:6480464 | CTD | |
| G | APP | amyloid beta (A4) precursor protein |
|
multiple interactions | ISO | 21 | 27,252,861 | 27,543,446 | RGD:6480464 | CTD | |
| G | AQP3 | aquaporin 3 (Gill blood group) |
|
multiple interactions | EXP | 9 | 33,441,152 | 33,447,631 | RGD:6480464 | CTD | |
| G | ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha |
|
increases expression | ISO | 17 | 79,825,597 | 79,829,282 | RGD:6480464 | CTD | |
| G | ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta |
|
multiple interactions | EXP | 12 | 15,094,950 | 15,114,562 | RGD:6480464 | CTD | |
| G | ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta |
|
increases expression | ISO | 12 | 15,094,950 | 15,114,562 | RGD:6480464 | CTD | |
| G | ARPC5 | actin related protein 2/3 complex, subunit 5, 16kDa |
|
increases expression | ISO | 1 | 183,595,328 | 183,605,076 | RGD:6480464 | CTD | |
| G | ASNS | asparagine synthetase (glutamine-hydrolyzing) |
|
decreases expression | EXP | 7 | 97,481,429 | 97,501,854 | RGD:6480464 | CTD | |
| G | ATF3 | activating transcription factor 3 |
|
multiple interactions | EXP | 1 | 212,738,676 | 212,794,119 | RGD:6480464 | CTD | |
| G | ATM | ataxia telangiectasia mutated |
|
multiple interactions | ISO | 11 | 108,093,559 | 108,239,826 | RGD:6480464 | CTD | |
| G | ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
increases expression | ISO | 12 | 57,031,959 | 57,039,852 | RGD:6480464 | CTD | |
| G | ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A |
|
increases expression | ISO | 3 | 113,465,866 | 113,530,905 | RGD:6480464 | CTD | |
| G | AURKB | aurora kinase B |
|
multiple interactions | EXP | 17 | 8,108,049 | 8,113,944 | RGD:6480464 | CTD | |
| G | B2M | beta-2-microglobulin |
|
increases expression | ISO | 15 | 45,003,685 | 45,010,357 | RGD:6480464 | CTD | |
| G | BAD | BCL2-associated agonist of cell death |
|
multiple interactions | ISO | 11 | 64,037,300 | 64,052,176 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
multiple interactions | EXP | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
multiple interactions | ISO | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
multiple interactions | ISO | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
multiple interactions | ISO | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
multiple interactions | EXP | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
multiple interactions | ISO | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BBC3 | BCL2 binding component 3 |
|
multiple interactions | EXP | 19 | 47,724,079 | 47,736,023 | RGD:6480464 | CTD | |
| G | BCHE | butyrylcholinesterase |
|
multiple interactions | ISO | 3 | 165,490,692 | 165,555,253 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | EXP | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
decreases expression | EXP | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
increases abundance | EXP | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | ISO | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | ISO | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | ISO | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | EXP | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | ISO | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2L1 | BCL2-like 1 |
|
multiple interactions | ISO | 20 | 30,252,261 | 30,310,656 | RGD:6480464 | CTD | |
| G | BCL2L1 | BCL2-like 1 |
|
multiple interactions | ISO | 20 | 30,252,261 | 30,310,656 | RGD:6480464 | CTD | |
| G | BCL2L14 | BCL2-like 14 (apoptosis facilitator) |
|
multiple interactions | EXP | 12 | 12,223,878 | 12,252,629 | RGD:6480464 | CTD | |
| G | BCL2L2 | BCL2-like 2 |
|
multiple interactions | ISO | 14 | 23,775,971 | 23,780,968 | RGD:6480464 | CTD | |
| G | BCMO1 | beta-carotene 15,15'-monooxygenase 1 |
|
multiple interactions | ISO | 16 | 81,272,296 | 81,324,747 | RGD:6480464 | CTD | |
| G | BDNF | brain-derived neurotrophic factor |
|
increases expression | ISO | 11 | 27,676,440 | 27,743,605 | RGD:6480464 | CTD | |
| G | BGLAP | bone gamma-carboxyglutamate (gla) protein |
|
affects binding | EXP | 1 | 156,211,951 | 156,213,123 | RGD:6480464 | CTD | |
| G | BGLAP | bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions | EXP | 1 | 156,211,951 | 156,213,123 | RGD:6480464 | CTD | |
| G | BGLAP | bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions | EXP | 1 | 156,211,951 | 156,213,123 | RGD:6480464 | CTD | |
| G | BGLAP | bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions | EXP | 1 | 156,211,951 | 156,213,123 | RGD:6480464 | CTD | |
| G | BIRC3 | baculoviral IAP repeat containing 3 |
|
multiple interactions | EXP | 11 | 102,188,181 | 102,210,134 | RGD:6480464 | CTD | |
| G | BIRC5 | baculoviral IAP repeat containing 5 |
|
decreases expression | EXP | 17 | 76,210,277 | 76,221,716 | RGD:6480464 | CTD | |
| G | BMP1 | bone morphogenetic protein 1 |
|
multiple interactions | ISO | 8 | 22,022,653 | 22,069,839 | RGD:6480464 | CTD | |
| G | BMP2 | bone morphogenetic protein 2 |
|
multiple interactions | ISO | 20 | 6,748,745 | 6,760,910 | RGD:6480464 | CTD | |
| G | BMP3 | bone morphogenetic protein 3 |
|
multiple interactions | ISO | 4 | 81,952,119 | 81,978,685 | RGD:6480464 | CTD | |
| G | BMP7 | bone morphogenetic protein 7 |
|
multiple interactions | ISO | 20 | 55,743,809 | 55,841,707 | RGD:6480464 | CTD | |
| G | BMPR1B | bone morphogenetic protein receptor, type IB |
|
increases expression | ISO | 4 | 95,679,128 | 96,079,601 | RGD:6480464 | CTD | |
| G | BUB1 | BUB1 mitotic checkpoint serine/threonine kinase |
|
multiple interactions | EXP | 2 | 111,395,409 | 111,435,684 | RGD:6480464 | CTD | |
| G | C3 | complement component 3 |
|
increases expression | ISO | 19 | 6,677,846 | 6,720,662 | RGD:6480464 | CTD | |
| G | CA2 | carbonic anhydrase II |
|
increases expression | ISO | 8 | 86,376,131 | 86,393,721 | RGD:6480464 | CTD | |
| G | CA9 | carbonic anhydrase IX |
|
multiple interactions | EXP | 9 | 35,673,915 | 35,681,156 | RGD:6480464 | CTD | |
| G | CASP2 | caspase 2, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 7 | 142,985,308 | 143,004,789 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
decreases activity | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP4 | caspase 4, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 11 | 104,813,594 | 104,839,325 | RGD:6480464 | CTD | |
| G | CASP6 | caspase 6, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 4 | 110,609,785 | 110,624,629 | RGD:6480464 | CTD | |
| G | CASP7 | caspase 7, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 10 | 115,438,921 | 115,490,668 | RGD:6480464 | CTD | |
| G | CASP8 | caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 2 | 202,098,166 | 202,152,434 | RGD:6480464 | CTD | |
| G | CASP8 | caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 2 | 202,098,166 | 202,152,434 | RGD:6480464 | CTD | |
| G | CASP9 | caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 1 | 15,818,769 | 15,851,285 | RGD:6480464 | CTD | |
| G | CASP9 | caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 1 | 15,818,769 | 15,851,285 | RGD:6480464 | CTD | |
| G | CAST | calpastatin |
|
increases expression | ISO | 5 | 95,997,741 | 96,110,387 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
affects expression | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
decreases response to substance | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
increases activity | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
increases expression | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
increases activity | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CBS | cystathionine-beta-synthase |
|
decreases expression | EXP | 21 | 44,473,301 | 44,496,472 | RGD:6480464 | CTD | |
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
affects expression | EXP | 17 | 32,582,296 | 32,584,222 | RGD:6480464 | CTD | |
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
decreases expression | ISO | 17 | 32,582,296 | 32,584,222 | RGD:6480464 | CTD | |
| G | CCL3 | chemokine (C-C motif) ligand 3 |
|
multiple interactions | ISO | 17 | 34,415,602 | 34,417,506 | RGD:6480464 | CTD | |
| G | CCNA1 | cyclin A1 |
|
multiple interactions | ISO | 13 | 37,005,967 | 37,017,019 | RGD:6480464 | CTD | |
| G | CCNB1 | cyclin B1 |
|
multiple interactions | ISO | 5 | 68,462,837 | 68,474,072 | RGD:6480464 | CTD | |
| G | CCNC | cyclin C |
|
multiple interactions | ISO | 6 | 99,990,263 | 100,016,690 | RGD:6480464 | CTD | |
| G | CCND1 | cyclin D1 |
|
multiple interactions | ISO | 11 | 69,455,873 | 69,469,242 | RGD:6480464 | CTD | |
| G | CCND1 | cyclin D1 |
|
multiple interactions | ISO | 11 | 69,455,873 | 69,469,242 | RGD:6480464 | CTD | |
| G | CCND1 | cyclin D1 |
|
decreases expression | EXP | 11 | 69,455,873 | 69,469,242 | RGD:6480464 | CTD | |
| G | CCND2 | cyclin D2 |
|
multiple interactions | EXP | 12 | 4,382,902 | 4,414,522 | RGD:6480464 | CTD | |
| G | CCND2 | cyclin D2 |
|
multiple interactions | ISO | 12 | 4,382,902 | 4,414,522 | RGD:6480464 | CTD | |
| G | CCND3 | cyclin D3 |
|
multiple interactions | ISO | 6 | 41,902,671 | 42,016,610 | RGD:6480464 | CTD | |
| G | CCNE2 | cyclin E2 |
|
multiple interactions | ISO | 8 | 95,892,452 | 95,907,482 | RGD:6480464 | CTD | |
| G | CCNG1 | cyclin G1 |
|
multiple interactions | ISO | 5 | 162,864,577 | 162,872,022 | RGD:6480464 | CTD | |
| G | CCNG1 | cyclin G1 |
|
multiple interactions | ISO | 5 | 162,864,577 | 162,872,022 | RGD:6480464 | CTD | |
| G | CD24 | CD24 molecule | multiple interactions | EXP | RGD:6480464 | CTD | |||||
| G | CD34 | CD34 molecule |
|
multiple interactions | EXP | 1 | 208,059,883 | 208,084,683 | RGD:6480464 | CTD | |
| G | CD40 | CD40 molecule, TNF receptor superfamily member 5 |
|
multiple interactions | EXP | 20 | 44,746,906 | 44,758,384 | RGD:6480464 | CTD | |
| G | CD48 | CD48 molecule |
|
increases expression | ISO | 1 | 160,648,536 | 160,681,641 | RGD:6480464 | CTD | |
| G | CD69 | CD69 molecule |
|
decreases expression | ISO | 12 | 9,905,082 | 9,913,497 | RGD:6480464 | CTD | |
| G | CD82 | CD82 molecule |
|
increases expression | ISO | 11 | 44,587,141 | 44,641,339 | RGD:6480464 | CTD | |
| G | CDC6 | cell division cycle 6 |
|
multiple interactions | EXP | 17 | 38,444,146 | 38,459,413 | RGD:6480464 | CTD | |
| G | CDH13 | cadherin 13, H-cadherin (heart) |
|
increases expression | ISO | 16 | 82,660,399 | 83,830,215 | RGD:6480464 | CTD | |
| G | CDH22 | cadherin 22, type 2 |
|
increases expression | ISO | 20 | 44,802,376 | 44,880,334 | RGD:6480464 | CTD | |
| G | CDK1 | cyclin-dependent kinase 1 |
|
multiple interactions | ISO | 10 | 62,538,089 | 62,554,610 | RGD:6480464 | CTD | |
| G | CDK11A | cyclin-dependent kinase 11A |
|
multiple interactions | EXP | 1 | 1,634,169 | 1,655,791 | RGD:6480464 | CTD | |
| G | CDK2 | cyclin-dependent kinase 2 |
|
multiple interactions | ISO | 12 | 56,360,556 | 56,366,568 | RGD:6480464 | CTD | |
| G | CDK4 | cyclin-dependent kinase 4 |
|
multiple interactions | ISO | 12 | 58,141,510 | 58,146,230 | RGD:6480464 | CTD | |
| G | CDK4 | cyclin-dependent kinase 4 |
|
multiple interactions | ISO | 12 | 58,141,510 | 58,146,230 | RGD:6480464 | CTD | |
| G | CDK6 | cyclin-dependent kinase 6 |
|
multiple interactions | ISO | 7 | 92,234,235 | 92,465,941 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions | ISO | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions | EXP | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions | EXP | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions | ISO | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression | ISO | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions | ISO | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
multiple interactions | ISO | 12 | 12,870,302 | 12,875,305 | RGD:6480464 | CTD | |
| G | CDKN2A | cyclin-dependent kinase inhibitor 2A |
|
multiple interactions | ISO | 9 | 21,967,751 | 21,994,490 | RGD:6480464 | CTD | |
| G | CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions | ISO | 19 | 33,790,840 | 33,793,430 | RGD:6480464 | CTD | |
| G | CEBPB | CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression | ISO | 20 | 48,807,120 | 48,809,227 | RGD:6480464 | CTD | |
| G | CFB | complement factor B |
|
multiple interactions | EXP | 6 | 31,913,721 | 31,919,861 | RGD:6480464 | CTD | |
| G | CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
|
multiple interactions | EXP | 7 | 117,120,017 | 117,308,719 | RGD:6480464 | CTD | |
| G | CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
|
increases activity | EXP | 7 | 117,120,017 | 117,308,719 | RGD:6480464 | CTD | |
| G | CHEK2 | checkpoint kinase 2 |
|
multiple interactions | ISO | 22 | 29,083,731 | 29,137,822 | RGD:6480464 | CTD | |
| G | CIT | citron (rho-interacting, serine/threonine kinase 21) |
|
multiple interactions | EXP | 12 | 120,123,595 | 120,315,095 | RGD:6480464 | CTD | |
| G | CLU | clusterin |
|
increases expression | ISO | 8 | 27,454,434 | 27,472,328 | RGD:6480464 | CTD | |
| G | CNN1 | calponin 1, basic, smooth muscle |
|
multiple interactions | EXP | 19 | 11,649,579 | 11,661,138 | RGD:6480464 | CTD | |
| G | CNN1 | calponin 1, basic, smooth muscle |
|
increases expression | ISO | 19 | 11,649,579 | 11,661,138 | RGD:6480464 | CTD | |
| G | CNTF | ciliary neurotrophic factor |
|
multiple interactions | EXP | 11 | 58,390,146 | 58,393,206 | RGD:6480464 | CTD | |
| G | COL10A1 | collagen, type X, alpha 1 |
|
increases expression | ISO | 6 | 116,440,085 | 116,447,296 | RGD:6480464 | CTD | |
| G | COL10A1 | collagen, type X, alpha 1 |
|
multiple interactions | ISO | 6 | 116,440,085 | 116,447,296 | RGD:6480464 | CTD | |
| G | COL1A1 | collagen, type I, alpha 1 |
|
increases expression | EXP | 17 | 48,261,457 | 48,279,000 | RGD:6480464 | CTD | |
| G | COL1A1 | collagen, type I, alpha 1 |
|
increases expression | ISO | 17 | 48,261,457 | 48,279,000 | RGD:6480464 | CTD | |
| G | COL1A2 | collagen, type I, alpha 2 |
|
increases expression | ISO | 7 | 94,023,873 | 94,060,544 | RGD:6480464 | CTD | |
| G | COL2A1 | collagen, type II, alpha 1 |
|
increases expression | ISO | 12 | 48,366,748 | 48,398,285 | RGD:6480464 | CTD | |
| G | CR2 | complement component (3d/Epstein Barr virus) receptor 2 |
|
multiple interactions | EXP | 1 | 207,627,645 | 207,663,240 | RGD:6480464 | CTD | |
| G | CRIP2 | cysteine-rich protein 2 |
|
increases expression | ISO | 14 | 105,939,275 | 105,946,507 | RGD:6480464 | CTD | |
| G | CRP | C-reactive protein, pentraxin-related |
|
multiple interactions | EXP | 1 | 159,682,079 | 159,684,379 | RGD:6480464 | CTD | |
| G | CRYAB | crystallin, alpha B |
|
increases expression | ISO | 11 | 111,779,350 | 111,782,473 | RGD:6480464 | CTD | |
| G | CSPG5 | chondroitin sulfate proteoglycan 5 (neuroglycan C) |
|
increases expression | ISO | 3 | 47,603,728 | 47,621,730 | RGD:6480464 | CTD | |
| G | CSRP1 | cysteine and glycine-rich protein 1 |
|
increases expression | ISO | 1 | 201,452,658 | 201,476,387 | RGD:6480464 | CTD | |
| G | CST6 | cystatin E/M |
|
increases expression | ISO | 11 | 65,779,462 | 65,780,976 | RGD:6480464 | CTD | |
| G | CTSD | cathepsin D |
|
multiple interactions | ISO | 11 | 1,773,982 | 1,785,222 | RGD:6480464 | CTD | |
| G | CTSK | cathepsin K |
|
increases expression | ISO | 1 | 150,768,684 | 150,780,917 | RGD:6480464 | CTD | |
| G | CTSO | cathepsin O |
|
multiple interactions | EXP | 4 | 156,845,270 | 156,875,048 | RGD:6480464 | CTD | |
| G | CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression | ISO | 4 | 74,735,109 | 74,737,019 | RGD:6480464 | CTD | |
| G | CXCL10 | chemokine (C-X-C motif) ligand 10 |
|
decreases expression | EXP | 4 | 76,942,269 | 76,944,689 | RGD:6480464 | CTD | |
| G | CXCL10 | chemokine (C-X-C motif) ligand 10 |
|
increases expression | EXP | 4 | 76,942,269 | 76,944,689 | RGD:6480464 | CTD | |
| G | CXCL6 | chemokine (C-X-C motif) ligand 6 |
|
increases expression | EXP | 4 | 74,702,273 | 74,704,477 | RGD:6480464 | CTD | |
| G | CXCL6 | chemokine (C-X-C motif) ligand 6 |
|
decreases expression | EXP | 4 | 74,702,273 | 74,704,477 | RGD:6480464 | CTD | |
| G | CXCL9 | chemokine (C-X-C motif) ligand 9 |
|
multiple interactions | EXP | 4 | 76,922,623 | 76,928,641 | RGD:6480464 | CTD | |
| G | CXCR5 | chemokine (C-X-C motif) receptor 5 |
|
multiple interactions | EXP | 11 | 118,754,475 | 118,766,980 | RGD:6480464 | CTD | |
| G | CYBRD1 | cytochrome b reductase 1 |
|
decreases expression | EXP | 2 | 172,378,757 | 172,414,643 | RGD:6480464 | CTD | |
| G | CYBRD1 | cytochrome b reductase 1 |
|
increases expression | EXP | 2 | 172,378,757 | 172,414,643 | RGD:6480464 | CTD | |
| G | CYP11A1 | cytochrome P450, family 11, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 74,630,103 | 74,660,081 | RGD:6480464 | CTD | |
| G | CYP11A1 | cytochrome P450, family 11, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 74,630,103 | 74,660,081 | RGD:6480464 | CTD | |
| G | CYP11A1 | cytochrome P450, family 11, subfamily A, polypeptide 1 |
|
increases expression | EXP | 15 | 74,630,103 | 74,660,081 | RGD:6480464 | CTD | |
| G | CYP11A1 | cytochrome P450, family 11, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 74,630,103 | 74,660,081 | RGD:6480464 | CTD | |
| G | CYP19A1 | cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
multiple interactions | EXP | 15 | 51,500,254 | 51,630,795 | RGD:6480464 | CTD | |
| G | CYP19A1 | cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
increases expression | EXP | 15 | 51,500,254 | 51,630,795 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | EXP | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
decreases activity | EXP | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | EXP | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
increases expression | ISO | 15 | 75,041,184 | 75,048,941 | RGD:6480464 | CTD | |
| G | CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
decreases activity | EXP | 19 | 41,349,443 | 41,356,352 | RGD:6480464 | CTD | |
| G | CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 |
|
decreases expression | ISO | 19 | 41,497,204 | 41,524,301 | RGD:6480464 | CTD | |
| G | CYP2B7P1 | cytochrome P450, family 2, subfamily B, polypeptide 7 pseudogene 1 |
|
multiple interactions | EXP | 19 | 41,430,170 | 41,456,565 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
decreases activity | EXP | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP3A | cytochrome P450, subfamily IIA (niphedipine oxidase) | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
multiple interactions | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP7A1 | cytochrome P450, family 7, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 8 | 59,402,737 | 59,412,720 | RGD:6480464 | CTD | |
| G | DAB2 | Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
|
decreases expression | ISO | 5 | 39,371,776 | 39,425,335 | RGD:6480464 | CTD | |
| G | DCLK1 | doublecortin-like kinase 1 |
|
increases expression | ISO | 13 | 36,342,789 | 36,705,514 | RGD:6480464 | CTD | |
| G | DDIT3 | DNA-damage-inducible transcript 3 |
|
multiple interactions | ISO | 12 | 57,910,371 | 57,914,300 | RGD:6480464 | CTD | |
| G | DKK1 | dickkopf WNT signaling pathway inhibitor 1 |
|
decreases expression | EXP | 10 | 54,074,041 | 54,077,417 | RGD:6480464 | CTD | |
| G | DLGAP5 | discs, large (Drosophila) homolog-associated protein 5 |
|
multiple interactions | EXP | 14 | 55,614,834 | 55,658,396 | RGD:6480464 | CTD | |
| G | DNAJC10 | DnaJ (Hsp40) homolog, subfamily C, member 10 |
|
multiple interactions | EXP | 2 | 183,580,999 | 183,643,255 | RGD:6480464 | CTD | |
| G | DNASE1 | deoxyribonuclease I |
|
multiple interactions | EXP | 16 | 3,702,940 | 3,708,096 | RGD:6480464 | CTD | |
| G | DPP4 | dipeptidyl-peptidase 4 |
|
multiple interactions | EXP | 2 | 162,848,755 | 162,931,052 | RGD:6480464 | CTD | |
| G | DPPA5 | developmental pluripotency associated 5 |
|
decreases expression | ISO | 6 | 74,062,785 | 74,063,999 | RGD:6480464 | CTD | |
| G | DUSP6 | dual specificity phosphatase 6 |
|
decreases expression | ISO | 12 | 89,741,837 | 89,746,296 | RGD:6480464 | CTD | |
| G | EDN1 | endothelin 1 |
|
multiple interactions | EXP | 6 | 12,290,529 | 12,297,427 | RGD:6480464 | CTD | |
| G | EDN3 | endothelin 3 |
|
multiple interactions | EXP | 20 | 57,875,499 | 57,901,047 | RGD:6480464 | CTD | |
| G | EDNRB | endothelin receptor type B |
|
increases expression | ISO | 13 13 |
78,469,616 78,513,393 |
78,549,664 78,549,674 |
RGD:6480464 | CTD | |
| G | EGFR | epidermal growth factor receptor |
|
decreases expression | EXP | 7 | 55,086,725 | 55,275,031 | RGD:6480464 | CTD | |
| G | EGLN1 | egl nine homolog 1 (C. elegans) |
|
multiple interactions | ISO | 1 | 231,499,497 | 231,560,790 | RGD:6480464 | CTD | |
| G | EGLN3 | egl nine homolog 3 (C. elegans) |
|
multiple interactions | EXP | 14 | 34,393,421 | 34,420,284 | RGD:6480464 | CTD | |
| G | EIF2S2 | eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa |
|
decreases expression | EXP | 20 | 32,676,115 | 32,700,085 | RGD:6480464 | CTD | |
| G | EIF3A | eukaryotic translation initiation factor 3, subunit A |
|
decreases expression | EXP | 10 | 120,794,541 | 120,840,334 | RGD:6480464 | CTD | |
| G | EIF3I | eukaryotic translation initiation factor 3, subunit I |
|
increases expression | ISO | 1 | 32,687,971 | 32,697,205 | RGD:6480464 | CTD | |
| G | EIF4A1 | eukaryotic translation initiation factor 4A1 |
|
decreases expression | EXP | 17 | 7,476,024 | 7,482,324 | RGD:6480464 | CTD | |
| G | EMP1 | epithelial membrane protein 1 |
|
multiple interactions | EXP | 12 | 13,349,602 | 13,369,708 | RGD:6480464 | CTD | |
| G | EMP3 | epithelial membrane protein 3 |
|
multiple interactions | EXP | 19 | 48,828,629 | 48,833,810 | RGD:6480464 | CTD | |
| G | EPAS1 | endothelial PAS domain protein 1 |
|
multiple interactions | EXP | 2 | 46,524,541 | 46,613,842 | RGD:6480464 | CTD | |
| G | EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) |
|
multiple interactions | EXP | 1 | 225,997,797 | 226,033,264 | RGD:6480464 | CTD | |
| G | EPHX2 | epoxide hydrolase 2, cytoplasmic |
|
multiple interactions | EXP | 8 | 27,348,519 | 27,402,439 | RGD:6480464 | CTD | |
| G | EPRS | glutamyl-prolyl-tRNA synthetase |
|
decreases expression | EXP | 1 | 220,141,942 | 220,220,000 | RGD:6480464 | CTD | |
| G | ERCC2 | excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
multiple interactions | ISO | 19 | 45,854,649 | 45,873,845 | RGD:6480464 | CTD | |
| G | ERCC2 | excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
multiple interactions | ISO | 19 | 45,854,649 | 45,873,845 | RGD:6480464 | CTD | |
| G | ERCC4 | excision repair cross-complementing rodent repair deficiency, complementation group 4 |
|
multiple interactions | ISO | 16 | 14,014,014 | 14,046,205 | RGD:6480464 | CTD | |
| G | ERCC5 | excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
multiple interactions | ISO | 13 | 103,498,191 | 103,528,351 | RGD:6480464 | CTD | |
| G | ESR1 | estrogen receptor 1 |
|
multiple interactions | ISO | 6 | 152,011,631 | 152,424,409 | RGD:6480464 | CTD | |
| G | ESR2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 14 | 64,693,751 | 64,805,268 | RGD:6480464 | CTD | |
| G | FABP6 | fatty acid binding protein 6, ileal |
|
multiple interactions | EXP | 5 | 159,614,374 | 159,665,729 | RGD:6480464 | CTD | |
| G | FBP1 | fructose-1,6-bisphosphatase 1 |
|
affects expression | ISO | 9 | 97,365,415 | 97,402,531 | RGD:6480464 | CTD | |
| G | FDXR | ferredoxin reductase |
|
increases expression | ISO | 17 | 72,858,619 | 72,869,156 | RGD:6480464 | CTD | |
| G | FLT1 | fms-related tyrosine kinase 1 |
|
decreases expression | EXP | 13 | 28,874,483 | 29,069,265 | RGD:6480464 | CTD | |
| G | FMO1 | flavin containing monooxygenase 1 |
|
multiple interactions | EXP | 1 | 171,217,663 | 171,255,113 | RGD:6480464 | CTD | |
| G | FMO5 | flavin containing monooxygenase 5 |
|
multiple interactions | EXP | 1 | 146,655,884 | 146,697,230 | RGD:6480464 | CTD | |
| G | FN1 | fibronectin 1 |
|
multiple interactions | EXP | 2 | 216,225,177 | 216,300,791 | RGD:6480464 | CTD | |
| G | FOS | FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression | ISO | 14 | 75,745,481 | 75,748,937 | RGD:6480464 | CTD | |
| G | FOXA2 | forkhead box A2 |
|
multiple interactions | ISO | 20 | 22,561,642 | 22,566,101 | RGD:6480464 | CTD | |
| G | FOXJ1 | forkhead box J1 |
|
multiple interactions | EXP | 17 | 74,132,414 | 74,137,380 | RGD:6480464 | CTD | |
| G | FOXJ1 | forkhead box J1 |
|
increases expression | ISO | 17 | 74,132,414 | 74,137,380 | RGD:6480464 | CTD | |
| G | FSHB | follicle stimulating hormone, beta polypeptide |
|
multiple interactions | ISO | 11 | 30,252,563 | 30,256,824 | RGD:6480464 | CTD | |
| G | FSHB | follicle stimulating hormone, beta polypeptide |
|
multiple interactions | ISO | 11 | 30,252,563 | 30,256,824 | RGD:6480464 | CTD | |
| G | FSHB | follicle stimulating hormone, beta polypeptide |
|
multiple interactions | ISO | 11 | 30,252,563 | 30,256,824 | RGD:6480464 | CTD | |
| G | FSHR | follicle stimulating hormone receptor |
|
multiple interactions | ISO | 2 | 49,189,296 | 49,381,666 | RGD:6480464 | CTD | |
| G | FTH1 | ferritin, heavy polypeptide 1 |
|
increases expression | ISO | 11 | 61,731,757 | 61,735,132 | RGD:6480464 | CTD | |
| G | FTL | ferritin, light polypeptide |
|
affects expression | ISO | 19 | 49,468,566 | 49,470,136 | RGD:6480464 | CTD | |
| G | FZD2 | frizzled family receptor 2 |
|
multiple interactions | EXP | 17 | 42,634,812 | 42,638,630 | RGD:6480464 | CTD | |
| G | G0S2 | G0/G1switch 2 |
|
multiple interactions | EXP | 1 | 209,848,670 | 209,849,735 | RGD:6480464 | CTD | |
| G | GABARAP | GABA(A) receptor-associated protein |
|
increases expression | ISO | 17 | 7,143,738 | 7,145,753 | RGD:6480464 | CTD | |
| G | GADD45B | growth arrest and DNA-damage-inducible, beta |
|
multiple interactions | ISO | 19 | 2,476,123 | 2,478,257 | RGD:6480464 | CTD | |
| G | GAK | cyclin G associated kinase |
|
multiple interactions | EXP | 4 | 843,065 | 926,174 | RGD:6480464 | CTD | |
| G | GAL | galanin/GMAP prepropeptide |
|
multiple interactions | ISO | 11 | 68,451,983 | 68,458,643 | RGD:6480464 | CTD | |
| G | GAMT | guanidinoacetate N-methyltransferase |
|
affects expression | ISO | 19 | 1,397,025 | 1,401,569 | RGD:6480464 | CTD | |
| G | GAPDH | glyceraldehyde-3-phosphate dehydrogenase |
|
increases expression | ISO | 12 | 6,643,585 | 6,647,537 | RGD:6480464 | CTD | |
| G | GARS | glycyl-tRNA synthetase |
|
decreases expression | EXP | 7 | 30,634,181 | 30,673,649 | RGD:6480464 | CTD | |
| G | GAS7 | growth arrest-specific 7 |
|
increases expression | ISO | 17 | 9,813,926 | 10,101,868 | RGD:6480464 | CTD | |
| G | GATA1 | GATA binding protein 1 (globin transcription factor 1) |
|
multiple interactions | EXP | X | 48,644,982 | 48,652,718 | RGD:6480464 | CTD | |
| G | GATA4 | GATA binding protein 4 |
|
increases expression | ISO | 8 | 11,561,717 | 11,617,509 | RGD:6480464 | CTD | |
| G | GBP2 | guanylate binding protein 2, interferon-inducible |
|
increases expression | ISO | 1 | 89,573,310 | 89,591,799 | RGD:6480464 | CTD | |
| G | GDF10 | growth differentiation factor 10 |
|
multiple interactions | ISO | 10 | 48,425,785 | 48,439,138 | RGD:6480464 | CTD | |
| G | GFAP | glial fibrillary acidic protein |
|
decreases expression | ISO | 17 | 42,982,994 | 42,992,920 | RGD:6480464 | CTD | |
| G | GFRA1 | GDNF family receptor alpha 1 |
|
multiple interactions | EXP | 10 | 117,816,436 | 118,033,126 | RGD:6480464 | CTD | |
| G | GGT1 | gamma-glutamyltransferase 1 |
|
multiple interactions | ISO | 22 | 24,979,718 | 25,024,972 | RGD:6480464 | CTD | |
| G | GH1 | growth hormone 1 |
|
multiple interactions | ISO | 17 | 61,994,563 | 61,996,198 | RGD:6480464 | CTD | |
| G | GLO1 | glyoxalase I |
|
affects expression | ISO | 6 | 38,643,701 | 38,670,952 | RGD:6480464 | CTD | |
| G | GLS | glutaminase |
|
multiple interactions | EXP | 2 | 191,745,547 | 191,830,278 | RGD:6480464 | CTD | |
| G | GNG3 | guanine nucleotide binding protein (G protein), gamma 3 |
|
increases expression | ISO | 11 | 62,475,066 | 62,476,678 | RGD:6480464 | CTD | |
| G | GNG4 | guanine nucleotide binding protein (G protein), gamma 4 |
|
increases expression | ISO | 1 | 235,710,985 | 235,814,054 | RGD:6480464 | CTD | |
| G | GPC1 | glypican 1 |
|
multiple interactions | ISO | 2 | 241,375,115 | 241,407,495 | RGD:6480464 | CTD | |
| G | GPD1 | glycerol-3-phosphate dehydrogenase 1 (soluble) |
|
multiple interactions | ISO | 12 | 50,497,602 | 50,505,103 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
multiple interactions | EXP | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
multiple interactions | ISO | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
multiple interactions | EXP | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
multiple interactions | ISO | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
increases expression | ISO | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
multiple interactions | EXP | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GPX2 | glutathione peroxidase 2 (gastrointestinal) |
|
multiple interactions | EXP | 14 | 65,405,870 | 65,409,623 | RGD:6480464 | CTD | |
| G | GPX2 | glutathione peroxidase 2 (gastrointestinal) |
|
multiple interactions | EXP | 14 | 65,405,870 | 65,409,623 | RGD:6480464 | CTD | |
| G | GPX4 | glutathione peroxidase 4 |
|
increases expression | ISO | 19 | 1,103,936 | 1,106,787 | RGD:6480464 | CTD | |
| G | GSK3B | glycogen synthase kinase 3 beta |
|
decreases expression | ISO | 3 | 119,540,800 | 119,813,264 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
multiple interactions | EXP | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
multiple interactions | ISO | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
multiple interactions | ISO | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
multiple interactions | ISO | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
multiple interactions | ISO | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
multiple interactions | ISO | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
multiple interactions | ISO | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
multiple interactions | ISO | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
multiple interactions | EXP | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
multiple interactions | EXP | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
affects response to substance | EXP | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM2 | glutathione S-transferase mu 2 (muscle) |
|
increases expression | ISO | 1 | 110,210,644 | 110,226,619 | RGD:6480464 | CTD | |
| G | GSTT1 | glutathione S-transferase theta 1 |
|
affects response to substance | EXP | 22 | 24,376,139 | 24,384,284 | RGD:6480464 | CTD | |
| G | GTF2H1 | general transcription factor IIH, polypeptide 1, 62kDa |
|
multiple interactions | EXP | 11 | 18,343,816 | 18,388,590 | RGD:6480464 | CTD | |
| G | GUCY1B3 | guanylate cyclase 1, soluble, beta 3 |
|
multiple interactions | ISO | 4 | 156,680,126 | 156,728,783 | RGD:6480464 | CTD | |
| G | GULOP | gulonolactone (L-) oxidase, pseudogene |
|
multiple interactions | ISO | 8 | 27,435,128 | 27,446,590 | RGD:6480464 | CTD | |
| G | GULOP | gulonolactone (L-) oxidase, pseudogene |
|
multiple interactions | ISO | 8 | 27,435,128 | 27,446,590 | RGD:6480464 | CTD | |
| G | GULOP | gulonolactone (L-) oxidase, pseudogene |
|
affects chemical synthesis | ISO | 8 | 27,435,128 | 27,446,590 | RGD:6480464 | CTD | |
| G | GUSB | glucuronidase, beta |
|
multiple interactions | ISO | 7 | 65,425,671 | 65,447,301 | RGD:6480464 | CTD | |
| G | GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
|
decreases expression | ISO | 14 | 25,100,160 | 25,103,432 | RGD:6480464 | CTD | |
| G | H2AFX | H2A histone family, member X |
|
multiple interactions | EXP | 11 | 118,964,584 | 118,966,177 | RGD:6480464 | CTD | |
| G | HADHA | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit |
|
decreases expression | ISO | 2 | 26,413,504 | 26,467,594 | RGD:6480464 | CTD | |
| G | HEPH | hephaestin |
|
multiple interactions | EXP | X | 65,382,433 | 65,487,231 | RGD:6480464 | CTD | |
| G | HERPUD1 | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
|
decreases expression | EXP | 16 | 56,965,748 | 56,977,793 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions | EXP | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions | EXP | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions | EXP | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions | EXP | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases degradation | EXP | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions | EXP | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions | ISO | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HK1 | hexokinase 1 |
|
multiple interactions | EXP | 10 | 71,029,756 | 71,161,638 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HOXA2 | homeobox A2 |
|
multiple interactions | ISO | 7 | 27,139,973 | 27,142,394 | RGD:6480464 | CTD | |
| G | HP | haptoglobin |
|
affects activity | EXP | 16 | 72,088,508 | 72,094,955 | RGD:6480464 | CTD | |
| G | HP | haptoglobin |
|
multiple interactions | ISO | 16 | 72,088,508 | 72,094,955 | RGD:6480464 | CTD | |
| G | HP | haptoglobin |
|
affects response to substance | EXP | 16 | 72,088,508 | 72,094,955 | RGD:6480464 | CTD | |
| G | HPRT1 | hypoxanthine phosphoribosyltransferase 1 |
|
multiple interactions | ISO | X | 133,594,175 | 133,634,698 | RGD:6480464 | CTD | |
| G | HSD17B1 | hydroxysteroid (17-beta) dehydrogenase 1 |
|
multiple interactions | ISO | 17 | 40,703,984 | 40,707,232 | RGD:6480464 | CTD | |
| G | HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 |
|
multiple interactions | ISO | 16 | 82,068,858 | 82,132,139 | RGD:6480464 | CTD | |
| G | HSD17B3 | hydroxysteroid (17-beta) dehydrogenase 3 |
|
multiple interactions | ISO | 9 | 98,997,589 | 99,064,434 | RGD:6480464 | CTD | |
| G | HSD3B1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
multiple interactions | ISO | 1 | 120,049,826 | 120,057,681 | RGD:6480464 | CTD | |
| G | HSD3B1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
increases expression | EXP | 1 | 120,049,826 | 120,057,681 | RGD:6480464 | CTD | |
| G | HSP90AB1 | heat shock protein 90kDa alpha (cytosolic), class B member 1 |
|
affects expression | ISO | 6 | 44,214,849 | 44,221,614 | RGD:6480464 | CTD | |
| G | HSPA1A | heat shock 70kDa protein 1A |
|
multiple interactions | EXP | 6 | 31,783,291 | 31,785,719 | RGD:6480464 | CTD | |
| G | HSPA5 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
multiple interactions | EXP | 9 | 127,997,127 | 128,003,666 | RGD:6480464 | CTD | |
| G | HSPA5 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
decreases expression | EXP | 9 | 127,997,127 | 128,003,666 | RGD:6480464 | CTD | |
| G | HSPA9 | heat shock 70kDa protein 9 (mortalin) |
|
decreases expression | EXP | 5 | 137,890,571 | 137,911,318 | RGD:6480464 | CTD | |
| G | HSPB1 | heat shock 27kDa protein 1 |
|
multiple interactions | EXP | 7 | 75,931,875 | 75,933,614 | RGD:6480464 | CTD | |
| G | HSPB1 | heat shock 27kDa protein 1 |
|
increases expression | ISO | 7 | 75,931,875 | 75,933,614 | RGD:6480464 | CTD | |
| G | HSPE1 | heat shock 10kDa protein 1 (chaperonin 10) |
|
multiple interactions | ISO | 2 | 198,364,721 | 198,368,187 | RGD:6480464 | CTD | |
| G | HSPE1 | heat shock 10kDa protein 1 (chaperonin 10) |
|
multiple interactions | ISO | 2 | 198,364,721 | 198,368,187 | RGD:6480464 | CTD | |
| G | HTN3 | histatin 3 |
|
multiple interactions | EXP | 4 | 70,894,130 | 70,902,255 | RGD:6480464 | CTD | |
| G | IARS | isoleucyl-tRNA synthetase |
|
decreases expression | EXP | 9 | 94,972,625 | 95,056,038 | RGD:6480464 | CTD | |
| G | ICAM1 | intercellular adhesion molecule 1 |
|
multiple interactions | EXP | 19 | 10,381,517 | 10,397,291 | RGD:6480464 | CTD | |
| G | IER3 | immediate early response 3 |
|
multiple interactions | EXP | 6 | 30,710,976 | 30,712,327 | RGD:6480464 | CTD | |
| G | IFI27 | interferon, alpha-inducible protein 27 |
|
increases expression | ISO | 14 | 94,577,079 | 94,583,033 | RGD:6480464 | CTD | |
| G | IFI27 | interferon, alpha-inducible protein 27 |
|
increases expression | ISO | 14 | 94,577,079 | 94,583,033 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
multiple interactions | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
decreases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IGF1R | insulin-like growth factor 1 receptor |
|
increases expression | ISO | 15 | 99,192,761 | 99,507,759 | RGD:6480464 | CTD | |
| G | IGFBP5 | insulin-like growth factor binding protein 5 |
|
multiple interactions | EXP | 2 | 217,536,828 | 217,560,272 | RGD:6480464 | CTD | |
| G | IHH | indian hedgehog |
|
increases expression | ISO | 2 | 219,919,142 | 219,925,238 | RGD:6480464 | CTD | |
| G | IKZF1 | IKAROS family zinc finger 1 (Ikaros) |
|
multiple interactions | EXP | 7 7 |
50,444,231 50,344,378 |
50,472,799 50,367,358 |
RGD:6480464 | CTD | |
| G | IKZF1 | IKAROS family zinc finger 1 (Ikaros) |
|
decreases activity | EXP | 7 7 |
50,444,231 50,344,378 |
50,472,799 50,367,358 |
RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
multiple interactions | ISO | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
multiple interactions | EXP | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
decreases expression | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
multiple interactions | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
affects expression | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | INSR | insulin receptor |
|
multiple interactions | ISO | 19 | 7,112,266 | 7,294,011 | RGD:6480464 | CTD | |
| G | IREB2 | iron-responsive element binding protein 2 |
|
multiple interactions | ISO | 15 | 78,730,518 | 78,793,798 | RGD:6480464 | CTD | |
| G | IRS1 | insulin receptor substrate 1 |
|
multiple interactions | ISO | 2 | 227,596,033 | 227,663,506 | RGD:6480464 | CTD | |
| G | ISL1 | ISL LIM homeobox 1 |
|
increases expression | ISO | 5 | 50,678,958 | 50,690,564 | RGD:6480464 | CTD | |
| G | JAG1 | jagged 1 |
|
decreases expression | ISO | 20 | 10,618,332 | 10,654,694 | RGD:6480464 | CTD | |
| G | KCNB1 | potassium voltage-gated channel, Shab-related subfamily, member 1 |
|
multiple interactions | EXP | 20 | 47,988,505 | 48,099,181 | RGD:6480464 | CTD | |
| G | KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) |
|
decreases expression | EXP | 4 | 55,944,426 | 55,991,762 | RGD:6480464 | CTD | |
| G | KIDINS220 | kinase D-interacting substrate, 220kDa |
|
decreases expression | ISO | 2 | 8,868,987 | 8,977,755 | RGD:6480464 | CTD | |
| G | KIF1B | kinesin family member 1B |
|
decreases expression | ISO | 1 | 10,270,764 | 10,441,661 | RGD:6480464 | CTD | |
| G | KIF1C | kinesin family member 1C |
|
decreases expression | ISO | 17 | 4,901,243 | 4,931,694 | RGD:6480464 | CTD | |
| G | KIF23 | kinesin family member 23 |
|
multiple interactions | EXP | 15 | 69,706,627 | 69,740,764 | RGD:6480464 | CTD | |
| G | KLRK1 | killer cell lectin-like receptor subfamily K, member 1 |
|
decreases expression | ISO | 12 | 10,524,952 | 10,542,653 | RGD:6480464 | CTD | |
| G | LGALS1 | lectin, galactoside-binding, soluble, 1 |
|
multiple interactions | EXP | 22 | 38,071,613 | 38,075,809 | RGD:6480464 | CTD | |
| G | LGALS3 | lectin, galactoside-binding, soluble, 3 |
|
increases expression | ISO | 14 | 55,595,935 | 55,612,148 | RGD:6480464 | CTD | |
| G | LHB | luteinizing hormone beta polypeptide |
|
multiple interactions | ISO | 19 | 49,519,237 | 49,520,347 | RGD:6480464 | CTD | |
| G | LHB | luteinizing hormone beta polypeptide |
|
multiple interactions | ISO | 19 | 49,519,237 | 49,520,347 | RGD:6480464 | CTD | |
| G | LHB | luteinizing hormone beta polypeptide |
|
multiple interactions | ISO | 19 | 49,519,237 | 49,520,347 | RGD:6480464 | CTD | |
| G | LHB | luteinizing hormone beta polypeptide |
|
multiple interactions | ISO | 19 | 49,519,237 | 49,520,347 | RGD:6480464 | CTD | |
| G | LHB | luteinizing hormone beta polypeptide |
|
multiple interactions | ISO | 19 | 49,519,237 | 49,520,347 | RGD:6480464 | CTD | |
| G | LHB | luteinizing hormone beta polypeptide |
|
multiple interactions | ISO | 19 | 49,519,237 | 49,520,347 | RGD:6480464 | CTD | |
| G | LHCGR | luteinizing hormone/choriogonadotropin receptor |
|
multiple interactions | ISO | 2 | 48,913,913 | 48,982,880 | RGD:6480464 | CTD | |
| G | LOXL2 | lysyl oxidase-like 2 |
|
decreases expression | EXP | 8 | 23,154,410 | 23,261,722 | RGD:6480464 | CTD | |
| G | LPHN1 | latrophilin 1 |
|
decreases expression | ISO | 19 | 14,258,549 | 14,316,997 | RGD:6480464 | CTD | |
| G | LXN | latexin |
|
increases expression | ISO | 3 | 158,384,203 | 158,390,482 | RGD:6480464 | CTD | |
| G | MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
multiple interactions | EXP | 22 | 38,597,939 | 38,612,518 | RGD:6480464 | CTD | |
| G | MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 |
|
increases expression | ISO | 7 | 77,646,374 | 79,082,890 | RGD:6480464 | CTD | |
| G | MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 |
|
multiple interactions | EXP | 18 | 56,338,618 | 56,417,370 | RGD:6480464 | CTD | |
| G | MAP2 | microtubule-associated protein 2 |
|
decreases expression | ISO | 2 | 210,288,771 | 210,598,834 | RGD:6480464 | CTD | |
| G | MAP2K3 | mitogen-activated protein kinase kinase 3 |
|
multiple interactions | EXP | 17 | 21,187,968 | 21,218,552 | RGD:6480464 | CTD | |
| G | MAP2K6 | mitogen-activated protein kinase kinase 6 |
|
multiple interactions | EXP | 17 | 67,410,838 | 67,538,470 | RGD:6480464 | CTD | |
| G | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions | EXP | 6 | 136,878,187 | 137,113,656 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
multiple interactions | ISO | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
increases phosphorylation | ISO | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
multiple interactions | ISO | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK14 | mitogen-activated protein kinase 14 |
|
multiple interactions | EXP | 6 | 35,995,454 | 36,079,013 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
multiple interactions | ISO | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
increases phosphorylation | ISO | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
multiple interactions | ISO | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK8 | mitogen-activated protein kinase 8 |
|
multiple interactions | EXP | 10 | 49,609,687 | 49,643,183 | RGD:6480464 | CTD | |
| G | MAPK9 | mitogen-activated protein kinase 9 |
|
multiple interactions | EXP | 5 | 179,660,594 | 179,719,071 | RGD:6480464 | CTD | |
| G | MCM4 | minichromosome maintenance complex component 4 |
|
multiple interactions | EXP | 8 | 48,872,763 | 48,890,720 | RGD:6480464 | CTD | |
| G | MDK | midkine (neurite growth-promoting factor 2) |
|
increases expression | ISO | 11 | 46,402,334 | 46,405,387 | RGD:6480464 | CTD | |
| G | MDM2 | MDM2 oncogene, E3 ubiquitin protein ligase |
|
multiple interactions | ISO | 12 | 69,201,971 | 69,239,320 | RGD:6480464 | CTD | |
| G | MEP1A | meprin A, alpha (PABA peptide hydrolase) |
|
multiple interactions | EXP | 6 | 46,761,094 | 46,807,519 | RGD:6480464 | CTD | |
| G | MET | met proto-oncogene (hepatocyte growth factor receptor) |
|
decreases expression | EXP | 7 | 116,312,459 | 116,438,440 | RGD:6480464 | CTD | |
| G | MGMT | O-6-methylguanine-DNA methyltransferase |
|
multiple interactions | ISO | 10 | 131,265,454 | 131,565,783 | RGD:6480464 | CTD | |
| G | MGST1 | microsomal glutathione S-transferase 1 |
|
increases expression | ISO | 12 | 16,500,076 | 16,530,123 | RGD:6480464 | CTD | |
| G | MKI67 | antigen identified by monoclonal antibody Ki-67 |
|
multiple interactions | EXP | 10 | 129,894,923 | 129,924,468 | RGD:6480464 | CTD | |
| G | MLH1 | mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
multiple interactions | EXP | 3 | 37,034,841 | 37,092,337 | RGD:6480464 | CTD | |
| G | MLH1 | mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
multiple interactions | EXP | 3 | 37,034,841 | 37,092,337 | RGD:6480464 | CTD | |
| G | MMP1 | matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions | EXP | 11 | 102,660,641 | 102,668,966 | RGD:6480464 | CTD | |
| G | MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) |
|
multiple interactions | EXP | 11 | 102,391,239 | 102,401,478 | RGD:6480464 | CTD | |
| G | MPO | myeloperoxidase |
|
multiple interactions | EXP | 17 | 56,347,217 | 56,358,296 | RGD:6480464 | CTD | |
| G | MPO | myeloperoxidase |
|
multiple interactions | ISO | 17 | 56,347,217 | 56,358,296 | RGD:6480464 | CTD | |
| G | MSH2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) |
|
multiple interactions | EXP | 2 | 47,630,206 | 47,710,367 | RGD:6480464 | CTD | |
| G | MSH2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) |
|
multiple interactions | EXP | 2 | 47,630,206 | 47,710,367 | RGD:6480464 | CTD | |
| G | MST1 | macrophage stimulating 1 (hepatocyte growth factor-like) |
|
multiple interactions | EXP | 3 | 49,721,380 | 49,726,196 | RGD:6480464 | CTD | |
| G | MST1L | macrophage stimulating 1-like |
|
multiple interactions | EXP | 1 | 17,081,401 | 17,090,975 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT3 | metallothionein 3 |
|
multiple interactions | EXP | 16 | 56,623,267 | 56,625,000 | RGD:6480464 | CTD | |
| G | MT3 | metallothionein 3 |
|
increases expression | ISO | 16 | 56,623,267 | 56,625,000 | RGD:6480464 | CTD | |
| G | MTHFD2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
|
decreases expression | EXP | 2 | 74,425,690 | 74,442,425 | RGD:6480464 | CTD | |
| G | MYB | v-myb myeloblastosis viral oncogene homolog (avian) |
|
multiple interactions | ISO | 6 | 135,502,453 | 135,540,311 | RGD:6480464 | CTD | |
| G | MYBL2 | v-myb myeloblastosis viral oncogene homolog (avian)-like 2 |
|
multiple interactions | EXP | 20 | 42,295,709 | 42,345,122 | RGD:6480464 | CTD | |
| G | MYH11 | myosin, heavy chain 11, smooth muscle |
|
increases expression | ISO | 16 | 15,796,992 | 15,950,887 | RGD:6480464 | CTD | |
| G | MYH6 | myosin, heavy chain 6, cardiac muscle, alpha |
|
increases expression | ISO | 14 | 23,851,199 | 23,877,486 | RGD:6480464 | CTD | |
| G | MYH7 | myosin, heavy chain 7, cardiac muscle, beta |
|
increases expression | ISO | 14 | 23,881,947 | 23,903,496 | RGD:6480464 | CTD | |
| G | MYH7 | myosin, heavy chain 7, cardiac muscle, beta |
|
increases expression | ISO | 14 | 23,881,947 | 23,903,496 | RGD:6480464 | CTD | |
| G | MYL2 | myosin, light chain 2, regulatory, cardiac, slow |
|
increases expression | ISO | 12 | 111,348,623 | 111,358,404 | RGD:6480464 | CTD | |
| G | MYO1A | myosin IA |
|
multiple interactions | EXP | 12 | 57,422,301 | 57,444,549 | RGD:6480464 | CTD | |
| G | MYO1E | myosin IE |
|
decreases expression | ISO | 15 | 59,428,168 | 59,665,071 | RGD:6480464 | CTD | |
| G | NAMPT | nicotinamide phosphoribosyltransferase |
|
multiple interactions | ISO | 7 | 105,888,731 | 105,925,638 | RGD:6480464 | CTD | |
| G | NARS | asparaginyl-tRNA synthetase |
|
decreases expression | EXP | 18 | 55,267,891 | 55,289,177 | RGD:6480464 | CTD | |
| G | NCALD | neurocalcin delta |
|
increases expression | ISO | 8 | 102,698,770 | 103,137,135 | RGD:6480464 | CTD | |
| G | NDRG1 | N-myc downstream regulated 1 |
|
multiple interactions | EXP | 8 | 134,249,414 | 134,309,547 | RGD:6480464 | CTD | |
| G | NDRG2 | NDRG family member 2 |
|
increases expression | ISO | 14 | 21,484,922 | 21,493,935 | RGD:6480464 | CTD | |
| G | NES | nestin |
|
decreases expression | ISO | 1 | 156,638,555 | 156,647,189 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions | EXP | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
increases expression | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFIB | nuclear factor I/B |
|
increases expression | ISO | 9 | 14,081,842 | 14,398,982 | RGD:6480464 | CTD | |
| G | NFYA | nuclear transcription factor Y, alpha |
|
multiple interactions | EXP | 6 | 41,040,707 | 41,070,146 | RGD:6480464 | CTD | |
| G | NINJ1 | ninjurin 1 |
|
multiple interactions | EXP | 9 | 95,883,771 | 95,896,570 | RGD:6480464 | CTD | |
| G | NKX2-1 | NK2 homeobox 1 |
|
multiple interactions | ISO | 14 | 36,985,602 | 36,989,430 | RGD:6480464 | CTD | |
| G | NKX2-1 | NK2 homeobox 1 |
|
multiple interactions | EXP | 14 | 36,985,602 | 36,989,430 | RGD:6480464 | CTD | |
| G | NKX2-5 | NK2 homeobox 5 |
|
increases expression | ISO | 5 | 172,659,107 | 172,662,315 | RGD:6480464 | CTD | |
| G | NME1 | NME/NM23 nucleoside diphosphate kinase 1 |
|
multiple interactions | EXP | 17 | 49,230,920 | 49,239,450 | RGD:6480464 | CTD | |
| G | NNAT | neuronatin |
|
increases expression | ISO | 20 | 36,149,607 | 36,152,092 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
multiple interactions | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
multiple interactions | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
increases activity | EXP | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
multiple interactions | EXP | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
multiple interactions | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
multiple interactions | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
decreases expression | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS3 | nitric oxide synthase 3 (endothelial cell) |
|
multiple interactions | ISO | 7 | 150,688,144 | 150,711,687 | RGD:6480464 | CTD | |
| G | NOS3 | nitric oxide synthase 3 (endothelial cell) |
|
multiple interactions | EXP | 7 | 150,688,144 | 150,711,687 | RGD:6480464 | CTD | |
| G | NOS3 | nitric oxide synthase 3 (endothelial cell) |
|
multiple interactions | ISO | 7 | 150,688,144 | 150,711,687 | RGD:6480464 | CTD | |
| G | NOS3 | nitric oxide synthase 3 (endothelial cell) |
|
increases phosphorylation | ISO | 7 | 150,688,144 | 150,711,687 | RGD:6480464 | CTD | |
| G | NOX1 | NADPH oxidase 1 |
|
increases expression | ISO | X | 100,098,313 | 100,129,334 | RGD:6480464 | CTD | |
| G | NOX4 | NADPH oxidase 4 |
|
increases expression | ISO | 11 | 89,057,521 | 89,322,779 | RGD:6480464 | CTD | |
| G | NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
|
increases expression | ISO | 5 | 170,814,708 | 170,837,888 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
multiple interactions | EXP | 5 | 142,657,496 | 142,815,077 | RGD:6480464 | CTD | |
| G | NR4A3 | nuclear receptor subfamily 4, group A, member 3 |
|
multiple interactions | EXP | 9 | 102,584,137 | 102,629,173 | RGD:6480464 | CTD | |
| G | NR5A1 | nuclear receptor subfamily 5, group A, member 1 |
|
multiple interactions | ISO | 9 | 127,243,515 | 127,269,699 | RGD:6480464 | CTD | |
| G | NREP | neuronal regeneration related protein |
|
increases expression | ISO | 5 | 111,065,000 | 111,312,628 | RGD:6480464 | CTD | |
| G | NRXN1 | neurexin 1 |
|
decreases expression | ISO | 2 | 50,145,643 | 51,259,674 | RGD:6480464 | CTD | |
| G | NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 |
|
increases expression | ISO | 9 | 87,283,466 | 87,638,505 | RGD:6480464 | CTD | |
| G | OGDH | oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
|
multiple interactions | ISO | 7 | 44,646,121 | 44,748,669 | RGD:6480464 | CTD | |
| G | OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
|
multiple interactions | EXP | 12 | 10,310,899 | 10,324,790 | RGD:6480464 | CTD | |
| G | OS9 | osteosarcoma amplified 9, endoplasmic reticulum lectin |
|
multiple interactions | EXP | 12 | 58,087,738 | 58,115,340 | RGD:6480464 | CTD | |
| G | P4HA2 | prolyl 4-hydroxylase, alpha polypeptide II |
|
decreases expression | EXP | 5 | 131,528,303 | 131,563,556 | RGD:6480464 | CTD | |
| G | P4HTM | prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum) |
|
multiple interactions | EXP | 3 | 49,027,341 | 49,044,582 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
multiple interactions | EXP | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
multiple interactions | ISO | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
multiple interactions | ISO | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
multiple interactions | EXP | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PCDHGA12 | protocadherin gamma subfamily A, 12 |
|
increases expression | ISO | 5 | 140,810,158 | 140,892,546 | RGD:6480464 | CTD | |
| G | PCK2 | phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
|
decreases expression | EXP | 14 | 24,563,483 | 24,573,339 | RGD:6480464 | CTD | |
| G | PCNA | proliferating cell nuclear antigen |
|
multiple interactions | ISO | 20 | 5,095,599 | 5,107,268 | RGD:6480464 | CTD | |
| G | PCNA | proliferating cell nuclear antigen |
|
multiple interactions | ISO | 20 | 5,095,599 | 5,107,268 | RGD:6480464 | CTD | |
| G | PCNA | proliferating cell nuclear antigen |
|
multiple interactions | ISO | 20 | 5,095,599 | 5,107,268 | RGD:6480464 | CTD | |
| G | PCP4 | Purkinje cell protein 4 |
|
increases expression | ISO | 21 | 41,239,347 | 41,301,322 | RGD:6480464 | CTD | |
| G | PDIA2 | protein disulfide isomerase family A, member 2 |
|
decreases expression | EXP | 16 | 333,118 | 337,209 | RGD:6480464 | CTD | |
| G | PDIA3 | protein disulfide isomerase family A, member 3 |
|
multiple interactions | EXP | 15 | 44,038,590 | 44,064,804 | RGD:6480464 | CTD | |
| G | PEBP1 | phosphatidylethanolamine binding protein 1 |
|
increases expression | ISO | 12 | 118,573,870 | 118,583,390 | RGD:6480464 | CTD | |
| G | PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
|
multiple interactions | ISO | X | 54,959,590 | 55,020,511 | RGD:6480464 | CTD | |
| G | PHGDH | phosphoglycerate dehydrogenase |
|
decreases expression | EXP | 1 | 120,254,419 | 120,286,849 | RGD:6480464 | CTD | |
| G | PHLDA1 | pleckstrin homology-like domain, family A, member 1 |
|
multiple interactions | EXP | 12 | 76,419,227 | 76,425,556 | RGD:6480464 | CTD | |
| G | PHLDA2 | pleckstrin homology-like domain, family A, member 2 |
|
multiple interactions | EXP | 11 | 2,949,503 | 2,950,650 | RGD:6480464 | CTD | |
| G | PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
decreases expression | ISO | 5 | 67,511,584 | 67,597,649 | RGD:6480464 | CTD | |
| G | PKM | pyruvate kinase, muscle |
|
increases expression | ISO | 15 | 72,491,370 | 72,523,727 | RGD:6480464 | CTD | |
| G | PLA2G16 | phospholipase A2, group XVI |
|
multiple interactions | EXP | 11 | 63,341,934 | 63,381,941 | RGD:6480464 | CTD | |
| G | PLAT | plasminogen activator, tissue |
|
multiple interactions | ISO | 8 | 42,032,236 | 42,065,194 | RGD:6480464 | CTD | |
| G | PLG | plasminogen |
|
multiple interactions | EXP | 6 | 161,123,225 | 161,175,086 | RGD:6480464 | CTD | |
| G | PLK1 | polo-like kinase 1 |
|
multiple interactions | EXP | 16 | 23,690,201 | 23,701,688 | RGD:6480464 | CTD | |
| G | PLK2 | polo-like kinase 2 |
|
decreases expression | ISO | 5 | 57,749,809 | 57,755,966 | RGD:6480464 | CTD | |
| G | PLS3 | plastin 3 |
|
increases expression | ISO | X | 114,795,177 | 114,885,181 | RGD:6480464 | CTD | |
| G | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 |
|
multiple interactions | EXP | 18 | 57,567,192 | 57,571,538 | RGD:6480464 | CTD | |
| G | PMP22 | peripheral myelin protein 22 |
|
decreases expression | EXP | 17 | 15,133,096 | 15,168,644 | RGD:6480464 | CTD | |
| G | PMP22 | peripheral myelin protein 22 |
|
decreases expression | EXP | 17 | 15,133,096 | 15,168,644 | RGD:6480464 | CTD | |
| G | PMP22 | peripheral myelin protein 22 |
|
multiple interactions | ISO | 17 | 15,133,096 | 15,168,644 | RGD:6480464 | CTD | |
| G | PNP | purine nucleoside phosphorylase |
|
affects expression | ISO | 14 | 20,937,538 | 20,946,165 | RGD:6480464 | CTD | |
| G | PON1 | paraoxonase 1 |
|
multiple interactions | EXP | 7 | 94,927,669 | 94,953,884 | RGD:6480464 | CTD | |
| G | PON1 | paraoxonase 1 |
|
multiple interactions | EXP | 7 | 94,927,669 | 94,953,884 | RGD:6480464 | CTD | |
| G | PON1 | paraoxonase 1 |
|
multiple interactions | EXP | 7 | 94,927,669 | 94,953,884 | RGD:6480464 | CTD | |
| G | PON1 | paraoxonase 1 |
|
multiple interactions | EXP | 7 | 94,927,669 | 94,953,884 | RGD:6480464 | CTD | |
| G | PON1 | paraoxonase 1 |
|
multiple interactions | EXP | 7 | 94,927,669 | 94,953,884 | RGD:6480464 | CTD | |
| G | PON1 | paraoxonase 1 |
|
multiple interactions | ISO | 7 | 94,927,669 | 94,953,884 | RGD:6480464 | CTD | |
| G | PON1 | paraoxonase 1 |
|
multiple interactions | EXP | 7 | 94,927,669 | 94,953,884 | RGD:6480464 | CTD | |
| G | PON1 | paraoxonase 1 |
|
decreases activity | EXP | 7 | 94,927,669 | 94,953,884 | RGD:6480464 | CTD | |
| G | PON1 | paraoxonase 1 |
|
multiple interactions | EXP | 7 | 94,927,669 | 94,953,884 | RGD:6480464 | CTD | |
| G | PON2 | paraoxonase 2 |
|
multiple interactions | EXP | 7 | 95,034,174 | 95,064,384 | RGD:6480464 | CTD | |
| G | POU5F1 | POU class 5 homeobox 1 |
|
increases expression | EXP | 6 | 31,132,114 | 31,138,451 | RGD:6480464 | CTD | |
| G | PPARG | peroxisome proliferator-activated receptor gamma |
|
multiple interactions | ISO | 3 | 12,329,349 | 12,475,855 | RGD:6480464 | CTD | |
| G | PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression | EXP | 4 | 23,793,644 | 23,891,700 | RGD:6480464 | CTD | |
| G | PRDX1 | peroxiredoxin 1 |
|
multiple interactions | ISO | 1 | 45,976,707 | 45,988,562 | RGD:6480464 | CTD | |
| G | PRDX1 | peroxiredoxin 1 |
|
multiple interactions | ISO | 1 | 45,976,707 | 45,988,562 | RGD:6480464 | CTD | |
| G | PRF1 | perforin 1 (pore forming protein) |
|
decreases expression | ISO | 10 | 72,357,104 | 72,362,531 | RGD:6480464 | CTD | |
| G | PRKCB | protein kinase C, beta |
|
increases expression | ISO | 16 | 23,847,300 | 24,231,932 | RGD:6480464 | CTD | |
| G | PRKCQ | protein kinase C, theta |
|
multiple interactions | EXP | 10 | 6,469,105 | 6,622,254 | RGD:6480464 | CTD | |
| G | PRL | prolactin |
|
multiple interactions | ISO | 6 | 22,287,473 | 22,303,082 | RGD:6480464 | CTD | |
| G | PRL | prolactin |
|
multiple interactions | ISO | 6 | 22,287,473 | 22,303,082 | RGD:6480464 | CTD | |
| G | PROS1 | protein S (alpha) |
|
decreases expression | ISO | 3 | 93,591,881 | 93,692,934 | RGD:6480464 | CTD | |
| G | PSMC3 | proteasome (prosome, macropain) 26S subunit, ATPase, 3 |
|
multiple interactions | EXP | 11 | 47,440,320 | 47,448,024 | RGD:6480464 | CTD | |
| G | PSME2 | proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
|
increases expression | ISO | 14 | 24,612,574 | 24,615,855 | RGD:6480464 | CTD | |
| G | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions | EXP | 1 | 186,640,944 | 186,649,559 | RGD:6480464 | CTD | |
| G | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions | ISO | 1 | 186,640,944 | 186,649,559 | RGD:6480464 | CTD | |
| G | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions | ISO | 1 | 186,640,944 | 186,649,559 | RGD:6480464 | CTD | |
| G | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions | ISO | 1 | 186,640,944 | 186,649,559 | RGD:6480464 | CTD | |
| G | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions | ISO | 1 | 186,640,944 | 186,649,559 | RGD:6480464 | CTD | |
| G | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions | ISO | 1 | 186,640,944 | 186,649,559 | RGD:6480464 | CTD | |
| G | PTHLH | parathyroid hormone-like hormone |
|
decreases expression | ISO | 12 | 28,111,017 | 28,124,916 | RGD:6480464 | CTD | |
| G | PTK2 | protein tyrosine kinase 2 |
|
decreases expression | ISO | 8 | 141,668,481 | 142,011,412 | RGD:6480464 | CTD | |
| G | PTN | pleiotrophin |
|
increases expression | ISO | 7 | 136,912,088 | 137,028,546 | RGD:6480464 | CTD | |
| G | RAB3B | RAB3B, member RAS oncogene family |
|
multiple interactions | EXP | 1 | 52,373,628 | 52,456,436 | RGD:6480464 | CTD | |
| G | RAB3B | RAB3B, member RAS oncogene family |
|
increases expression | ISO | 1 | 52,373,628 | 52,456,436 | RGD:6480464 | CTD | |
| G | RAB6A | RAB6A, member RAS oncogene family |
|
multiple interactions | EXP | 11 | 73,386,683 | 73,472,201 | RGD:6480464 | CTD | |
| G | RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
|
multiple interactions | EXP | 7 | 6,414,126 | 6,443,598 | RGD:6480464 | CTD | |
| G | RAD50 | RAD50 homolog (S. cerevisiae) |
|
multiple interactions | ISO | 5 | 131,892,616 | 131,980,313 | RGD:6480464 | CTD | |
| G | RAD51C | RAD51 homolog C (S. cerevisiae) |
|
multiple interactions | EXP | 17 | 56,769,963 | 56,811,692 | RGD:6480464 | CTD | |
| G | RAD54B | RAD54 homolog B (S. cerevisiae) |
|
multiple interactions | EXP | 8 | 95,384,188 | 95,487,343 | RGD:6480464 | CTD | |
| G | RAN | RAN, member RAS oncogene family |
|
increases expression | ISO | 12 | 131,356,617 | 131,360,826 | RGD:6480464 | CTD | |
| G | RCAN1 | regulator of calcineurin 1 |
|
multiple interactions | EXP | 21 | 35,888,782 | 35,987,382 | RGD:6480464 | CTD | |
| G | RGS8 | regulator of G-protein signaling 8 |
|
decreases expression | ISO | 1 | 182,615,792 | 182,642,067 | RGD:6480464 | CTD | |
| G | RPH3A | rabphilin 3A homolog (mouse) |
|
increases expression | ISO | 12 | 113,229,549 | 113,336,686 | RGD:6480464 | CTD | |
| G | RPS29 | ribosomal protein S29 |
|
increases expression | ISO | 14 | 50,044,039 | 50,053,094 | RGD:6480464 | CTD | |
| G | RPSA | ribosomal protein SA |
|
affects expression | ISO | 3 | 39,448,204 | 39,454,033 | RGD:6480464 | CTD | |
| G | RUNX2 | runt-related transcription factor 2 |
|
multiple interactions | EXP | 6 | 45,296,054 | 45,518,819 | RGD:6480464 | CTD | |
| G | RUNX2 | runt-related transcription factor 2 |
|
increases expression | ISO | 6 | 45,296,054 | 45,518,819 | RGD:6480464 | CTD | |
| G | RUNX2 | runt-related transcription factor 2 |
|
multiple interactions | ISO | 6 | 45,296,054 | 45,518,819 | RGD:6480464 | CTD | |
| G | RUNX2 | runt-related transcription factor 2 |
|
multiple interactions | ISO | 6 | 45,296,054 | 45,518,819 | RGD:6480464 | CTD | |
| G | S100A10 | S100 calcium binding protein A10 |
|
increases expression | ISO | 1 | 151,955,386 | 151,966,714 | RGD:6480464 | CTD | |
| G | S100A6 | S100 calcium binding protein A6 |
|
increases expression | ISO | 1 | 153,507,076 | 153,508,717 | RGD:6480464 | CTD | |
| G | S100B | S100 calcium binding protein B |
|
increases expression | ISO | 21 | 48,018,531 | 48,025,035 | RGD:6480464 | CTD | |
| G | S100G | S100 calcium binding protein G |
|
multiple interactions | EXP | X | 16,668,281 | 16,672,791 | RGD:6480464 | CTD | |
| G | SDC2 | syndecan 2 |
|
decreases expression | ISO | 8 | 97,505,882 | 97,624,037 | RGD:6480464 | CTD | |
| G | SDHA | succinate dehydrogenase complex, subunit A, flavoprotein (Fp) |
|
multiple interactions | ISO | 5 | 218,356 | 256,815 | RGD:6480464 | CTD | |
| G | SEC61G | Sec61 gamma subunit |
|
decreases expression | ISO | 7 | 54,819,940 | 54,826,939 | RGD:6480464 | CTD | |
| G | SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
decreases expression | EXP | 18 | 61,554,939 | 61,571,124 | RGD:6480464 | CTD | |
| G | SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions | ISO | 7 | 100,770,370 | 100,782,547 | RGD:6480464 | CTD | |
| G | SESN2 | sestrin 2 |
|
multiple interactions | EXP | 1 | 28,585,963 | 28,609,002 | RGD:6480464 | CTD | |
| G | SFTPB | surfactant protein B |
|
multiple interactions | EXP | 2 | 85,884,440 | 85,895,864 | RGD:6480464 | CTD | |
| G | SFTPB | surfactant protein B |
|
multiple interactions | EXP | 2 | 85,884,440 | 85,895,864 | RGD:6480464 | CTD | |
| G | SFTPB | surfactant protein B |
|
multiple interactions | ISO | 2 | 85,884,440 | 85,895,864 | RGD:6480464 | CTD | |
| G | SFTPC | surfactant protein C |
|
decreases expression | ISO | 8 | 22,019,184 | 22,021,992 | RGD:6480464 | CTD | |
| G | SHMT2 | serine hydroxymethyltransferase 2 (mitochondrial) |
|
decreases expression | EXP | 12 | 57,623,356 | 57,628,718 | RGD:6480464 | CTD | |
| G | SI | sucrase-isomaltase (alpha-glucosidase) |
|
multiple interactions | EXP | 3 | 164,696,686 | 164,796,283 | RGD:6480464 | CTD | |
| G | SLC11A2 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
decreases expression | EXP | 12 | 51,373,566 | 51,422,058 | RGD:6480464 | CTD | |
| G | SLC11A2 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression | EXP | 12 | 51,373,566 | 51,422,058 | RGD:6480464 | CTD | |
| G | SLC22A7 | solute carrier family 22 (organic anion transporter), member 7 |
|
increases transport | EXP | 6 | 43,265,998 | 43,273,276 | RGD:6480464 | CTD | |
| G | SLC23A1 | solute carrier family 23 (nucleobase transporters), member 1 |
|
multiple interactions | EXP | 5 | 138,702,885 | 138,719,039 | RGD:6480464 | CTD | |
| G | SLC23A1 | solute carrier family 23 (nucleobase transporters), member 1 |
|
increases transport | EXP | 5 | 138,702,885 | 138,719,039 | RGD:6480464 | CTD | |
| G | SLC23A1 | solute carrier family 23 (nucleobase transporters), member 1 |
|
increases expression | EXP | 5 | 138,702,885 | 138,719,039 | RGD:6480464 | CTD | |
| G | SLC23A1 | solute carrier family 23 (nucleobase transporters), member 1 |
|
decreases expression | EXP | 5 | 138,702,885 | 138,719,039 | RGD:6480464 | CTD | |
| G | SLC23A1 | solute carrier family 23 (nucleobase transporters), member 1 |
|
affects abundance | EXP | 5 | 138,702,885 | 138,719,039 | RGD:6480464 | CTD | |
| G | SLC23A1 | solute carrier family 23 (nucleobase transporters), member 1 |
|
affects transport | EXP | 5 | 138,702,885 | 138,719,039 | RGD:6480464 | CTD | |
| G | SLC23A1 | solute carrier family 23 (nucleobase transporters), member 1 |
|
increases expression | ISO | 5 | 138,702,885 | 138,719,039 | RGD:6480464 | CTD | |
| G | SLC23A1 | solute carrier family 23 (nucleobase transporters), member 1 |
|
affects uptake | ISO | 5 | 138,702,885 | 138,719,039 | RGD:6480464 | CTD | |
| G | SLC23A2 | solute carrier family 23 (nucleobase transporters), member 2 |
|
multiple interactions | EXP | 20 | 4,833,002 | 4,990,939 | RGD:6480464 | CTD | |
| G | SLC23A2 | solute carrier family 23 (nucleobase transporters), member 2 |
|
multiple interactions | EXP | 20 | 4,833,002 | 4,990,939 | RGD:6480464 | CTD | |
| G | SLC23A2 | solute carrier family 23 (nucleobase transporters), member 2 |
|
decreases expression | ISO | 20 | 4,833,002 | 4,990,939 | RGD:6480464 | CTD | |
| G | SLC23A2 | solute carrier family 23 (nucleobase transporters), member 2 |
|
increases expression | ISO | 20 | 4,833,002 | 4,990,939 | RGD:6480464 | CTD | |
| G | SLC23A2 | solute carrier family 23 (nucleobase transporters), member 2 |
|
increases expression | ISO | 20 | 4,833,002 | 4,990,939 | RGD:6480464 | CTD | |
| G | SLC23A2 | solute carrier family 23 (nucleobase transporters), member 2 |
|
increases abundance | ISO | 20 | 4,833,002 | 4,990,939 | RGD:6480464 | CTD | |
| G | SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 |
|
increases expression | ISO | 1 | 43,391,046 | 43,424,847 | RGD:6480464 | CTD | |
| G | SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 |
|
increases expression | ISO | 17 | 7,185,054 | 7,191,367 | RGD:6480464 | CTD | |
| G | SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions | ISO | 17 | 7,185,054 | 7,191,367 | RGD:6480464 | CTD | |
| G | SMC6 | structural maintenance of chromosomes 6 |
|
decreases expression | EXP | 2 | 17,845,079 | 17,935,096 | RGD:6480464 | CTD | |
| G | SNCA | synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression | ISO | 4 | 90,645,250 | 90,759,447 | RGD:6480464 | CTD | |
| G | SOD1 | superoxide dismutase 1, soluble |
|
multiple interactions | EXP | 21 | 33,031,935 | 33,041,244 | RGD:6480464 | CTD | |
| G | SOD1 | superoxide dismutase 1, soluble |
|
affects abundance | ISO | 21 | 33,031,935 | 33,041,244 | RGD:6480464 | CTD | |
| G | SOD1 | superoxide dismutase 1, soluble |
|
multiple interactions | ISO | 21 | 33,031,935 | 33,041,244 | RGD:6480464 | CTD | |
| G | SOD1 | superoxide dismutase 1, soluble |
|
multiple interactions | EXP | 21 | 33,031,935 | 33,041,244 | RGD:6480464 | CTD | |
| G | SOD1 | superoxide dismutase 1, soluble |
|
multiple interactions | ISO | 21 | 33,031,935 | 33,041,244 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
multiple interactions | ISO | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
multiple interactions | ISO | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
multiple interactions | ISO | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
multiple interactions | EXP | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
multiple interactions | ISO | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
increases response to substance | EXP | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
multiple interactions | ISO | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
increases expression | EXP | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
multiple interactions | ISO | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SORT1 | sortilin 1 |
|
increases expression | ISO | 1 | 109,852,187 | 109,940,563 | RGD:6480464 | CTD | |
| G | SOX10 | SRY (sex determining region Y)-box 10 |
|
increases expression | ISO | 22 | 38,368,319 | 38,380,539 | RGD:6480464 | CTD | |
| G | SOX11 | SRY (sex determining region Y)-box 11 |
|
decreases expression | ISO | 2 | 5,832,799 | 5,841,517 | RGD:6480464 | CTD | |
| G | SOX2 | SRY (sex determining region Y)-box 2 |
|
increases expression | EXP | 3 | 181,429,712 | 181,432,224 | RGD:6480464 | CTD | |
| G | SP1 | Sp1 transcription factor |
|
decreases expression | EXP | 12 | 53,773,979 | 53,810,230 | RGD:6480464 | CTD | |
| G | SP3 | Sp3 transcription factor |
|
decreases expression | EXP | 2 | 174,771,187 | 174,830,430 | RGD:6480464 | CTD | |
| G | SP4 | Sp4 transcription factor |
|
decreases expression | EXP | 7 | 21,467,689 | 21,554,162 | RGD:6480464 | CTD | |
| G | SP7 | Sp7 transcription factor |
|
increases expression | ISO | 12 | 53,720,359 | 53,730,004 | RGD:6480464 | CTD | |
| G | SP7 | Sp7 transcription factor |
|
multiple interactions | ISO | 12 | 53,720,359 | 53,730,004 | RGD:6480464 | CTD | |
| G | SPARC | secreted protein, acidic, cysteine-rich (osteonectin) |
|
multiple interactions | EXP | 5 | 151,040,657 | 151,066,615 | RGD:6480464 | CTD | |
| G | SPARCL1 | SPARC-like 1 (hevin) |
|
increases expression | ISO | 4 | 88,394,487 | 88,450,655 | RGD:6480464 | CTD | |
| G | SPP1 | secreted phosphoprotein 1 |
|
multiple interactions | EXP | 4 | 88,896,802 | 88,904,563 | RGD:6480464 | CTD | |
| G | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions | ISO | 20 | 35,973,088 | 36,033,821 | RGD:6480464 | CTD | |
| G | SST | somatostatin |
|
increases expression | ISO | 3 | 187,386,694 | 187,388,201 | RGD:6480464 | CTD | |
| G | STAR | steroidogenic acute regulatory protein |
|
multiple interactions | ISO | 8 | 38,000,218 | 38,008,600 | RGD:6480464 | CTD | |
| G | STAT1 | signal transducer and activator of transcription 1, 91kDa |
|
multiple interactions | EXP | 2 | 191,833,762 | 191,878,976 | RGD:6480464 | CTD | |
| G | STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions | EXP | 17 | 40,465,343 | 40,540,513 | RGD:6480464 | CTD | |
| G | STK17B | serine/threonine kinase 17b |
|
multiple interactions | EXP | 2 | 196,998,307 | 197,036,336 | RGD:6480464 | CTD | |
| G | SUCLG2 | succinate-CoA ligase, GDP-forming, beta subunit |
|
affects expression | ISO | 3 | 67,410,884 | 67,705,038 | RGD:6480464 | CTD | |
| G | SULT1A1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
decreases expression | EXP | 16 | 28,616,908 | 28,634,907 | RGD:6480464 | CTD | |
| G | SULT1A3 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 |
|
decreases expression | EXP | 16 | 30,210,549 | 30,215,650 | RGD:6480464 | CTD | |
| G | SULT1C3 | sulfotransferase family, cytosolic, 1C, member 3 |
|
multiple interactions | EXP | 2 | 108,863,651 | 108,881,807 | RGD:6480464 | CTD | |
| G | SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
|
multiple interactions | EXP | 19 | 48,373,723 | 48,389,654 | RGD:6480464 | CTD | |
| G | SYT7 | synaptotagmin VII |
|
increases expression | ISO | 11 | 61,281,188 | 61,348,344 | RGD:6480464 | CTD | |
| G | TAGLN | transgelin |
|
multiple interactions | EXP | 11 | 117,070,040 | 117,075,508 | RGD:6480464 | CTD | |
| G | TAGLN | transgelin |
|
increases expression | EXP | 11 | 117,070,040 | 117,075,508 | RGD:6480464 | CTD | |
| G | TARS | threonyl-tRNA synthetase |
|
decreases expression | EXP | 5 | 33,440,802 | 33,468,196 | RGD:6480464 | CTD | |
| G | TAZ | tafazzin |
|
multiple interactions | EXP | X | 153,639,877 | 153,650,065 | RGD:6480464 | CTD | |
| G | TBC1D4 | TBC1 domain family, member 4 |
|
multiple interactions | ISO | 13 | 75,858,809 | 76,056,250 | RGD:6480464 | CTD | |
| G | TF | transferrin |
|
multiple interactions | EXP | 3 | 133,464,977 | 133,497,850 | RGD:6480464 | CTD | |
| G | TF | transferrin |
|
increases expression | ISO | 3 | 133,464,977 | 133,497,850 | RGD:6480464 | CTD | |
| G | TFF2 | trefoil factor 2 |
|
multiple interactions | EXP | 21 | 43,766,466 | 43,771,208 | RGD:6480464 | CTD | |
| G | TFRC | transferrin receptor (p90, CD71) |
|
multiple interactions | ISO | 3 | 195,776,155 | 195,809,032 | RGD:6480464 | CTD | |
| G | TGFB1 | transforming growth factor, beta 1 |
|
multiple interactions | ISO | 19 | 41,836,812 | 41,859,831 | RGD:6480464 | CTD | |
| G | TGFB1 | transforming growth factor, beta 1 |
|
multiple interactions | EXP | 19 | 41,836,812 | 41,859,831 | RGD:6480464 | CTD | |
| G | TGFB1 | transforming growth factor, beta 1 |
|
multiple interactions | EXP | 19 | 41,836,812 | 41,859,831 | RGD:6480464 | CTD | |
| G | TGFB1 | transforming growth factor, beta 1 |
|
increases expression | ISO | 19 | 41,836,812 | 41,859,831 | RGD:6480464 | CTD | |
| G | TGFB2 | transforming growth factor, beta 2 |
|
increases expression | ISO | 1 | 218,518,676 | 218,617,961 | RGD:6480464 | CTD | |
| G | TH | tyrosine hydroxylase |
|
increases expression | ISO | 11 | 2,185,159 | 2,193,035 | RGD:6480464 | CTD | |
| G | TH | tyrosine hydroxylase |
|
decreases expression | ISO | 11 | 2,185,159 | 2,193,035 | RGD:6480464 | CTD | |
| G | TIMP1 | TIMP metallopeptidase inhibitor 1 |
|
increases expression | EXP | X | 47,441,690 | 47,446,190 | RGD:6480464 | CTD | |
| G | TIMP1 | TIMP metallopeptidase inhibitor 1 |
|
increases expression | ISO | X | 47,441,690 | 47,446,190 | RGD:6480464 | CTD | |
| G | TIMP1 | TIMP metallopeptidase inhibitor 1 |
|
multiple interactions | ISO | X | 47,441,690 | 47,446,190 | RGD:6480464 | CTD | |
| G | TM4SF1 | transmembrane 4 L six family member 1 |
|
multiple interactions | EXP | 3 | 149,086,805 | 149,095,568 | RGD:6480464 | CTD | |
| G | TMEM176B | transmembrane protein 176B |
|
increases expression | ISO | 7 | 150,488,375 | 150,498,448 | RGD:6480464 | CTD | |
| G | TMPRSS6 | transmembrane protease, serine 6 |
|
multiple interactions | EXP | 22 | 37,461,479 | 37,499,693 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | EXP | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b |
|
decreases expression | EXP | 8 | 119,935,796 | 119,964,383 | RGD:6480464 | CTD | |
| G | TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions | EXP | 3 | 172,223,298 | 172,241,297 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | EXP | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | ISO | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | EXP | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | ISO | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | EXP | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | ISO | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | EXP | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53TG1 | TP53 target 1 (non-protein coding) |
|
multiple interactions | EXP | 7 | 86,954,663 | 86,974,808 | RGD:6480464 | CTD | |
| G | TPT1 | tumor protein, translationally-controlled 1 |
|
increases expression | ISO | 13 | 45,911,304 | 45,915,297 | RGD:6480464 | CTD | |
| G | TRH | thyrotropin-releasing hormone |
|
decreases expression | ISO | 3 | 129,693,114 | 129,696,778 | RGD:6480464 | CTD | |
| G | TRIB3 | tribbles homolog 3 (Drosophila) |
|
multiple interactions | EXP | 20 | 361,308 | 378,203 | RGD:6480464 | CTD | |
| G | TRIB3 | tribbles homolog 3 (Drosophila) |
|
decreases expression | EXP | 20 | 361,308 | 378,203 | RGD:6480464 | CTD | |
| G | TRIP10 | thyroid hormone receptor interactor 10 |
|
multiple interactions | EXP | 19 | 6,739,707 | 6,751,529 | RGD:6480464 | CTD | |
| G | TRPC5 | transient receptor potential cation channel, subfamily C, member 5 |
|
multiple interactions | EXP | X | 111,017,542 | 111,326,004 | RGD:6480464 | CTD | |
| G | TSHB | thyroid stimulating hormone, beta |
|
multiple interactions | ISO | 1 | 115,572,415 | 115,576,941 | RGD:6480464 | CTD | |
| G | TSPO | translocator protein (18kDa) |
|
increases expression | ISO | 22 | 43,547,520 | 43,559,248 | RGD:6480464 | CTD | |
| G | TXN | thioredoxin |
|
multiple interactions | ISO | 9 | 113,006,092 | 113,018,920 | RGD:6480464 | CTD | |
| G | TXNIP | thioredoxin interacting protein |
|
increases expression | ISO | 1 | 145,438,462 | 145,442,635 | RGD:6480464 | CTD | |
| G | TYR | tyrosinase |
|
multiple interactions | EXP | 11 | 88,911,040 | 89,028,927 | RGD:6480464 | CTD | |
| G | TYR | tyrosinase |
|
increases oxidation | EXP | 11 | 88,911,040 | 89,028,927 | RGD:6480464 | CTD | |
| G | UBE2A | ubiquitin-conjugating enzyme E2A |
|
multiple interactions | EXP | X | 118,708,499 | 118,718,381 | RGD:6480464 | CTD | |
| G | UGT1A10 | UDP glucuronosyltransferase 1 family, polypeptide A10 |
|
multiple interactions | EXP | 2 | 234,545,123 | 234,681,951 | RGD:6480464 | CTD | |
| G | UGT1A3 | UDP glucuronosyltransferase 1 family, polypeptide A3 |
|
multiple interactions | ISO | 2 | 234,637,773 | 234,681,945 | RGD:6480464 | CTD | |
| G | UGT1A6 | UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
multiple interactions | ISO | 2 | 234,600,321 | 234,681,951 | RGD:6480464 | CTD | |
| G | UGT1A9 | UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
multiple interactions | EXP | 2 | 234,580,544 | 234,681,951 | RGD:6480464 | CTD | |
| G | UGT2B15 | UDP glucuronosyltransferase 2 family, polypeptide B15 |
|
multiple interactions | EXP | 4 | 69,512,315 | 69,536,494 | RGD:6480464 | CTD | |
| G | UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
multiple interactions | ISO | 4 | 69,402,902 | 69,434,245 | RGD:6480464 | CTD | |
| G | UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
multiple interactions | ISO | 4 | 69,402,902 | 69,434,245 | RGD:6480464 | CTD | |
| G | UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
multiple interactions | ISO | 4 | 69,402,902 | 69,434,245 | RGD:6480464 | CTD | |
| G | UNG | uracil-DNA glycosylase |
|
multiple interactions | ISO | 12 | 109,535,399 | 109,548,798 | RGD:6480464 | CTD | |
| G | UROD | uroporphyrinogen decarboxylase |
|
increases expression | ISO | 1 | 45,477,805 | 45,481,341 | RGD:6480464 | CTD | |
| G | VCAM1 | vascular cell adhesion molecule 1 |
|
multiple interactions | EXP | 1 | 101,185,196 | 101,204,601 | RGD:6480464 | CTD | |
| G | VHL | von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
|
multiple interactions | EXP | 3 | 10,183,319 | 10,195,354 | RGD:6480464 | CTD | |
| G | VIM | vimentin |
|
increases expression | ISO | 10 | 17,270,258 | 17,279,592 | RGD:6480464 | CTD | |
| G | VIP | vasoactive intestinal peptide |
|
affects expression | ISO | 6 | 153,071,932 | 153,080,900 | RGD:6480464 | CTD | |
| G | VNN3 | vanin 3 |
|
affects expression | EXP | 6 | 133,043,926 | 133,055,904 | RGD:6480464 | CTD | |
| G | VNN3 | vanin 3 |
|
increases expression | EXP | 6 | 133,043,926 | 133,055,904 | RGD:6480464 | CTD | |
| G | VRK1 | vaccinia related kinase 1 |
|
multiple interactions | EXP | 14 | 97,263,684 | 97,347,951 | RGD:6480464 | CTD | |
| G | VTN | vitronectin |
|
increases expression | ISO | 17 | 26,694,298 | 26,697,373 | RGD:6480464 | CTD | |
| G | WARS | tryptophanyl-tRNA synthetase |
|
decreases expression | EXP | 14 | 100,800,125 | 100,842,680 | RGD:6480464 | CTD | |
| G | WARS2 | tryptophanyl tRNA synthetase 2, mitochondrial |
|
decreases expression | EXP | 1 | 119,573,839 | 119,683,295 | RGD:6480464 | CTD | |
| G | WWTR1 | WW domain containing transcription regulator 1 |
|
multiple interactions | EXP | 3 | 149,235,022 | 149,421,060 | RGD:6480464 | CTD | |
| G | XPNPEP2 | X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound |
|
multiple interactions | EXP | X | 128,872,946 | 128,903,525 | RGD:6480464 | CTD | |
| G | XRCC1 | X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
multiple interactions | EXP | 19 | 44,047,464 | 44,079,730 | RGD:6480464 | CTD | |
| G | XRCC1 | X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
multiple interactions | EXP | 19 | 44,047,464 | 44,079,730 | RGD:6480464 | CTD | |
| G | YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
|
affects expression | ISO | 17 | 1,247,834 | 1,303,556 | RGD:6480464 | CTD | |
| G | ZDHHC2 | zinc finger, DHHC-type containing 2 |
|
increases expression | ISO | 8 | 17,013,836 | 17,080,241 | RGD:6480464 | CTD | |
| G | ZNF165 | zinc finger protein 165 |
|
multiple interactions | EXP | 6 | 28,048,482 | 28,057,341 | RGD:6480464 | CTD | |
L-dehydroascorbic acid
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | EXP | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
increases expression | EXP | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
increases expression | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CYCS | cytochrome c, somatic |
|
affects localization | EXP | 7 | 25,158,270 | 25,164,980 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
multiple interactions | EXP | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
multiple interactions | ISO | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions | ISO | 1 | 186,640,944 | 186,649,559 | RGD:6480464 | CTD | |
| G | SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 |
|
decreases transport | EXP | 1 | 43,391,046 | 43,424,847 | RGD:6480464 | CTD | |
| G | SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 |
|
affects uptake | EXP | 1 | 43,391,046 | 43,424,847 | RGD:6480464 | CTD | |
| G | SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 |
|
affects transport | ISO | 1 | 43,391,046 | 43,424,847 | RGD:6480464 | CTD | |
| G | SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 |
|
affects transport | EXP | 12 | 8,071,824 | 8,088,892 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
multiple interactions | EXP | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
increases expression | EXP | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
Term paths to the root
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term